Stocks in play: Orogen Royalties Inc.
Has authorized a grant of 156,000 Restricted Share Units, 156,000 Deferred Share Units and 238,000 Stock Options to independent board members. The grant is pursuant to the Company's Omnibus Equity Incentive Compensation Plan that was approved by shareholders on October 27, 2022, and forms part of part of the independent board's 2023 remuneration. Orogen Royalties Inc. shares V.OGN are trading unchanged at $0.53.
Read:
The Future of Lithium in Nevada: Companies Pour in Money, with Expansions Underway
Addressing the USA’s 200 to 1 Security Protection Gap is a Serious Concern for Tech Companies
Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer